Once More Unto the Breach

Notes from my first in-person mega-conference in two years

Written byBob Grant
| 5 min read
Illustration of a crowd of people wearing protective masks
Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

With January’s Omicron wave behind us, giant research organizations have again decided to hold their annual conferences in person. I started writing this dispatch from the bowels of the immense Ernest N. Morial Convention Center in downtown New Orleans in mid-April. I was there, with more than 14,000 attendees involved in the enterprise of cancer science, to attend the annual meeting of the American Association for Cancer Research. The AACR and similarly sized groups have held their massive meetings virtually for the past two years as the pandemic engulfed the world, shuttering labs and scuttling events around the globe.

This year, the AACR jumped back into the fray and invited its sizeable community into a common space to share, collaborate, and network. Over the years, I’ve been to several AACR conferences and meetings of other large, professional organizations to cover the proceedings, speak with researchers, and keep tabs on the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile

Published In

Bacteria, virus, cell 3D
Summer 2022

Know Thy Enemy

Understanding how SARS-CoV-2 and other viruses interact with their victims

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies